1. Anaphylaxis and beta blockers: glucagon could be the answer

   Comment 21 January 2013 Pages: 2 - 2

2. Anaphylaxis and beta blockers: glucagon could be the answer

   Comment 21 January 2013 Pages: 2 - 2

3. Nomifensine - a Hoechst cover-up?

   Comment 21 January 2013 Pages: 2 - 2

4. Polypharmacy can be life-threatening

   Case report 21 January 2013 Pages: 2 - 2

5. Minimising cyclophosphamide toxicity

   Review 21 January 2013 Pages: 3 - 3

6. The PAF effects of triazolam are not seen in vivo

   Comment 21 January 2013 Pages: 3 - 3

7. The PAF effects of triazolam are not seen in vivo

   Volunteers 21 January 2013 Pages: 3 - 3

8. True extent of interleukin 2 toxicity obscured

   Case report 21 January 2013 Pages: 3 - 3

9. Amfebutamone

   Incidence study 21 January 2013 Pages: 4 - 4

10. Amiodarone

    Incidence study 21 January 2013 Pages: 4 - 4

11. Amiodarone

    Incidence study 21 January 2013 Pages: 5 - 5

12. Amoxapine/haloperidol

    Case report 21 January 2013 Pages: 5 - 5

13. Antineoplastics

    Incidence study 21 January 2013 Pages: 5 - 5

14. Antipsychotics

    Clinical study 21 January 2013 Pages: 5 - 5

15. Aspirin

    Incidence study 21 January 2013 Pages: 5 - 5

16. Beclomethasone

    Case reports 21 January 2013 Pages: 5 - 5

17. Bromocriptine

    Case report 21 January 2013 Pages: 5 - 5

18. Bromogalactogluconate

    Case report 21 January 2013 Pages: 5 - 5

19. Bucillamine

    Case report 21 January 2013 Pages: 6 - 6

20. Carbamazepine

    Case report 21 January 2013 Pages: 6 - 6

21. Charcoal

    Case report 21 January 2013 Pages: 6 - 6

22. Chlormethine/psoralen

    Case report 21 January 2013 Pages: 6 - 6

23. Cisplatin/etoposide

    Incidence study 21 January 2013 Pages: 6 - 6

24. Clomipramine

    Case report 21 January 2013 Pages: 6 - 6

25. Clozapine

    Case report 21 January 2013 Pages: 6 - 6

26. Corticosteroids

    Case report 21 January 2013 Pages: 6 - 6

27. Corticosteroids

    Case reports 21 January 2013 Pages: 7 - 7

28. Corticosteroids

    Clinical study 21 January 2013 Pages: 7 - 7

29. Cyclosporin

    Clinical study 21 January 2013 Pages: 7 - 7

30. Dapsone

    Case report 21 January 2013 Pages: 7 - 7

31. Diclofenac

    Case report 21 January 2013 Pages: 7 - 7

32. Digoxin

    Case report 21 January 2013 Pages: 7 - 7

33. Enalapril

    Incidence study 21 January 2013 Pages: 7 - 7

34. Epinephrine/dipivefrine

    Correspondence 21 January 2013 Pages: 7 - 7

35. Ethambutol

    Case report 21 January 2013 Pages: 7 - 7

36. Etretinate

    Case report 21 January 2013 Pages: 7 - 7

37. Fluorouracil

    Case report 21 January 2013 Pages: 7 - 7

38. Fluorouracil + sparfosic acid

    Incidence study 21 January 2013 Pages: 7 - 7

39. Fluoxetine

    Case report 21 January 2013 Pages: 8 - 8

40. Foscarnet

    Case report 21 January 2013 Pages: 8 - 8

41. Granulocyte colony-stimulating factor

    Incidence study 21 January 2013 Pages: 8 - 8

42. Granulocyte colony-stimulating factor

    Incidence study 21 January 2013 Pages: 8 - 8

43. Halothane/suxamethonium chloride

    Case report 21 January 2013 Pages: 8 - 8

44. Heparin

    Case report 21 January 2013 Pages: 8 - 8

45. Ifosfamide

    Incidence study 21 January 2013 Pages: 8 - 8

46. Ifosfamide

    Incidence study 21 January 2013 Pages: 8 - 8

47. Immunoglobulin

    Case report 21 January 2013 Pages: 8 - 8

48. Insulin human

    Clinical study 21 January 2013 Pages: 8 - 8

49. Interferon alpha 2A

    Case report 21 January 2013 Pages: 9 - 9

50. Interleukin 2

    Case report 21 January 2013 Pages: 9 - 9